Literature DB >> 10213371

Evidence for different ABC-transporters in Caco-2 cells modulating drug uptake.

H Gutmann1, G Fricker, M Török, S Michael, C Beglinger, J Drewe.   

Abstract

PURPOSE: Secretory systems contribute to drug absorption in the gastrointestinal tract. The purpose of this study was the identification of members of the ATP binding cassette superfamily of secretory transport proteins that may potentially modulate drug absorption in Caco-2 cells, which are an important cellular model predicting enteral absorption of drugs.
METHODS: Kinetic studies as well as PCR- and Western blot studies with confluent epithelial layers of human Caco-2 cells.
RESULTS: The study demonstrates functional expression of multidrug resistance related protein (MRP) and P-glycoprotein (P-gp) in Caco-2 cells: 1) Efflux studies with the MRP specific substrate glutathion-methylfluorescein (GS-MF) showed functional activity of MRP in Caco-2 cells preloaded with the metabolic precursor of GS-MF, chloromethylfluoresceine-diacetate, CMFDA. Excretion of GS-MF was decreased in presence of the MRP-blocker M K-571.2) Transport experiments with cyclosporin A demonstrated the functional activity of P-gp. Cellular accumulation was increased in presence of the P-gp blocking agent SDZ-PSC 833. 3) The expression of the 190 kDa protein MRP and the 170 kDa protein P-gp in Caco-2 cells was shown by Western blot analysis with specific monoclonal antibodies. 4) The expression of MRP-mRNA in Caco-2 cells was detected by RT-PCR and compared with the MRP over-expressing cell line H69AR. MRP primers recognize specifically human MRP1 (GenBank accession number L05628), but not all other published sequences of MRP (MRP2-MRP6). P-gp expression on mRNA-level was also confirmed by RT-PCR.
CONCLUSIONS: The data demonstrate that besides P-gp, multidrug resistance related protein (MRP) is functionally expressed in Caco-2 cells and contributes to the active excretion of substrates in this cell line.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10213371     DOI: 10.1023/a:1018825819249

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  28 in total

Review 1.  Molecular aspects of hepatobiliary transport.

Authors:  M Müller; P L Jansen
Journal:  Am J Physiol       Date:  1997-06

2.  Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa.

Authors:  A R Hilgers; R A Conradi; P S Burton
Journal:  Pharm Res       Date:  1990-09       Impact factor: 4.200

3.  Antigens associated with multidrug resistance in H69AR, a small cell lung cancer cell line.

Authors:  S E Mirski; S P Cole
Journal:  Cancer Res       Date:  1989-10-15       Impact factor: 12.701

4.  P-Glycoprotein (P-gp) mediated efflux in Caco-2 cell monolayers: the influence of culturing conditions and drug exposure on P-gp expression levels.

Authors:  P Anderle; E Niederer; W Rubas; C Hilgendorf; H Spahn-Langguth; H Wunderli-Allenspach; H P Merkle; P Langguth
Journal:  J Pharm Sci       Date:  1998-06       Impact factor: 3.534

5.  Evidence for a polarized efflux system in CACO-2 cells capable of modulating cyclosporin A transport.

Authors:  P F Augustijns; T P Bradshaw; L S Gan; R W Hendren; D R Thakker
Journal:  Biochem Biophys Res Commun       Date:  1993-12-15       Impact factor: 3.575

Review 6.  Biochemistry of multidrug resistance mediated by the multidrug transporter.

Authors:  M M Gottesman; I Pastan
Journal:  Annu Rev Biochem       Date:  1993       Impact factor: 23.643

7.  Tissue distribution of the multidrug resistance protein.

Authors:  M J Flens; G J Zaman; P van der Valk; M A Izquierdo; A B Schroeijers; G L Scheffer; P van der Groep; M de Haas; C J Meijer; R J Scheper
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

8.  Age-dependent expression of P-glycoprotein gp170 in Caco-2 cell monolayers.

Authors:  K I Hosoya; K J Kim; V H Lee
Journal:  Pharm Res       Date:  1996-06       Impact factor: 4.200

9.  Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells.

Authors:  P Artursson
Journal:  J Pharm Sci       Date:  1990-06       Impact factor: 3.534

10.  Mechanisms of hepatic transport of cyclosporin A: an explanation for its cholestatic action?

Authors:  G Fricker; A Fahr
Journal:  Yale J Biol Med       Date:  1997 Jul-Aug
View more
  20 in total

1.  Predicting oral absorption of drugs: a case study with a novel class of antimicrobial agents.

Authors:  Allen R Hilgers; Donald P Smith; John J Biermacher; Jeffrey S Day; Jana L Jensen; Sandra M Sims; Wade J Adams; Janice M Friis; Joe Palandra; John D Hosley; Eric M Shobe; Philip S Burton
Journal:  Pharm Res       Date:  2003-08       Impact factor: 4.200

2.  Role of multidrug resistance protein 2 (MRP2) in glutathione-bimane efflux from Caco-2 and rat renal proximal tubule cells.

Authors:  S A Terlouw; R Masereeuw; P H van den Broek; S Notenboom; F G Russel
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

3.  The efflux of flavonoids morin, isorhamnetin-3-O-rutinoside and diosmetin-7-O-beta-D-xylopyranosyl-(1-6) -beta-D-glucopyranoside in the human intestinal cell line caco-2.

Authors:  Xiaojuan Tian; Xiaoda Yang; Kui Wang; Xiuwei Yang
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

4.  Rifampicin alters the expression of reference genes used to normalize real-time quantitative RT-PCR data.

Authors:  Johanna Weiss; Dirk Theile; Walter Emil Haefeli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-07-24       Impact factor: 3.000

5.  The limitations of renal epithelial cell line HK-2 as a model of drug transporter expression and function in the proximal tubule.

Authors:  Sarah E Jenkinson; Git W Chung; Ellen van Loon; Nur S Bakar; Abigail M Dalzell; Colin D A Brown
Journal:  Pflugers Arch       Date:  2012-09-27       Impact factor: 3.657

6.  Atorvastatin transport in the Caco-2 cell model: contributions of P-glycoprotein and the proton-monocarboxylic acid co-transporter.

Authors:  X Wu; L R Whitfield; B H Stewart
Journal:  Pharm Res       Date:  2000-02       Impact factor: 4.200

7.  Characterizing the expression of CYP3A4 and efflux transporters (P-gp, MRP1, and MRP2) in CYP3A4-transfected Caco-2 cells after induction with sodium butyrate and the phorbol ester 12-O-tetradecanoylphorbol-13-acetate.

Authors:  C L Cummins; L M Mangravite; L Z Benet
Journal:  Pharm Res       Date:  2001-08       Impact factor: 4.200

8.  Monitoring intracellular pH changes in response to osmotic stress and membrane transport activity using 5-chloromethylfluorescein.

Authors:  Aline Salvi; J Mark Quillan; Wolfgang Sadée
Journal:  AAPS PharmSci       Date:  2002

9.  A modified coumarinic acid-based cyclic prodrug of an opioid peptide: its enzymatic and chemical stability and cell permeation characteristics.

Authors:  Hui Ouyang; Fuxing Tang; Teruna J Siahaan; Ronald T Borchardt
Journal:  Pharm Res       Date:  2002-06       Impact factor: 4.200

10.  pH-Sensitive hydrogels as gastrointestinal tract absorption enhancers: transport mechanisms of salmon calcitonin and other model molecules using the Caco-2 cell model.

Authors:  Madeline Torres-Lugo; Marcos García; Rae Record; Nicholas A Peppas
Journal:  Biotechnol Prog       Date:  2002 May-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.